Skip to content
10-Q

Quarterly Report

Arcadia Biosciences, Inc. RKDA

0001193125-25-272375

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 1.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.37M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.36M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.36M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $16K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.88M
Operating Cash Flow Q3 2025 · Dec 31, 2024 −$9.6M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$7.42M
Short Term Investments Q3 2025 · Sep 30, 2025 $4.77M
Short Term Investments Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.24M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.29M
Current Liabilities Q3 2025 · Dec 31, 2024 $2.56M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.14M
Total Liabilities Q3 2025 · Dec 31, 2024 $7.29M
Current Assets Q3 2025 · Sep 30, 2025 $8.39M
Current Assets Q3 2025 · Dec 31, 2024 $9.24M
Total Assets Q3 2025 · Sep 30, 2025 $8.58M
Total Assets Q3 2025 · Dec 31, 2024 $13.52M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.62
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.73
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.18
Eps Basic Q3 2025 · Sep 30, 2025 $0.63
Eps Basic Q3 2025 · Sep 30, 2025 −$0.73
Eps Basic Q3 2025 · Sep 30, 2024 −$1.18
Eps Basic Q3 2025 · Sep 30, 2024 −$2.18
Sga Expense Q3 2025 · Sep 30, 2025 $1.57M
Sga Expense Q3 2025 · Sep 30, 2025 $5.43M
Sga Expense Q3 2025 · Sep 30, 2024 $2.24M
Sga Expense Q3 2025 · Sep 30, 2024 $6.99M
Rd Expense Q3 2025 · Sep 30, 2025 $0
Rd Expense Q3 2025 · Sep 30, 2025 $9K
Rd Expense Q3 2025 · Sep 30, 2024 $24K
Rd Expense Q3 2025 · Sep 30, 2024 $40K
Net Income Q3 2025 · Sep 30, 2025 $856K
Net Income Q3 2025 · Sep 30, 2025 −$1M
Net Income Q3 2025 · Sep 30, 2024 −$1.61M
Net Income Q3 2025 · Sep 30, 2024 −$2.97M
Operating Income Q3 2025 · Sep 30, 2025 −$1.15M
Operating Income Q3 2025 · Sep 30, 2025 −$1.13M
Operating Income Q3 2025 · Sep 30, 2024 −$1.76M
Operating Income Q3 2025 · Sep 30, 2024 −$1.37M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $884K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.39M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.03M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.14M
Revenue Q3 2025 · Sep 30, 2025 $1.3M
Revenue Q3 2025 · Sep 30, 2025 $3.96M
Revenue Q3 2025 · Sep 30, 2024 $1.54M
Revenue Q3 2025 · Sep 30, 2024 $3.83M